Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial78

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of KRAS wild-type metastatic colorectal cancer: Final results of a phase II open-label clinical trial48

Views

Views
July 202519
August 20251
September 202517
October 20252
November 20253
December 20256
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States25
Brazil15
United Kingdom2
Argentina1
Barbados1
Algeria1
Ecuador1
Paraguay1
South Africa1
 

Top cities views

Views
Dallas15
San Jose3
Rio de Janeiro2
Alejandro Korn1
Arlington1
Asunción1
Bordj el Kiffan1
Brasília1
Bridgetown1
Canoas1